Sumanta Pal

Racial and ethnic differences in perceptions of germline or somatic DNA sequencing among patients with advanced prostate, urothelial, or kidney cancer.

E. Philip, C. Bergerot, P. Bergerot, 2023, Journal of Genetic Counseling.

Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective study

J. Brugarolas, N. Agarwal, E. Lam, 2023, EClinicalMedicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.

Unique Spectrum of Activating BRAF Alterations in Prostate Cancer

H. Ebrahimi, N. Agarwal, B. Mahal, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Barriers to Clinical Trial Implementation Among Community Care Centers.

N. Chawla, E. Plotkin, R. Oyer, 2024, JAMA network open.

Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study.

T. Dorff, E. Philip, M. Salgia, 2023, Clinical genitourinary cancer.

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

L. Pachter, S. Priceman, L. Budde, 2024, Nature medicine.

Co-primary endpoint analysis of HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in patients with muscle-invasive bladder cancer (MIBC).

C. Kyriakopoulos, T. Dorff, Menggang Yu, 2023, Journal of Clinical Oncology.

Outcomes of patients with brain metastases from renal cell carcinoma treated with first-line therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

T. Choueiri, I. Davis, A. Kapoor, 2023, Journal of Clinical Oncology.